Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.23USD
20 Apr 2018
Change (% chg)

$0.18 (+3.56%)
Prev Close
$5.05
Open
$5.06
Day's High
$5.33
Day's Low
$4.98
Volume
50,940
Avg. Vol
49,752
52-wk High
$14.09
52-wk Low
$4.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.12 -0.584
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 1.24 1.80 1.00 --
Quarter Ending Sep-18 5 1.10 1.90 0.50 --
Year Ending Dec-18 6 4.90 7.40 3.00 5.92
Year Ending Dec-19 7 16.14 22.90 8.82 23.19
Earnings (per share)
Quarter Ending Jun-18 5 -0.56 -0.42 -0.74 --
Quarter Ending Sep-18 5 -0.54 -0.37 -0.75 --
Year Ending Dec-18 6 -2.18 -1.65 -2.85 -2.30
Year Ending Dec-19 7 -1.99 -1.05 -3.20 -13.74
LT Growth Rate (%) 2 25.75 97.20 -45.70 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) 50.61 110.89 5.71
Price to Book (MRQ) 0.46 13.58 5.37
Price to Tangible Book (MRQ) 6.16 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 61.24 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.12 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -13.83 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.69 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago -8.57 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 3.77 5.30 2.98
LT Debt to Equity (MRQ) 0.44 22.96 12.18
Total Debt to Equity (MRQ) 0.44 24.62 16.45
Interest Coverage (TTM) -2.14 -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -290.58 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -987.15 -- --
EBITD - 5 Yr. Avg -- -574.75 10.96
Operating Margin (TTM) -991.86 -718.53 4.73
Operating Margin - 5 Yr. Avg. -- -596.06 6.40
Pre-Tax Margin (TTM) -1,003.38 -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.42 6.81
Net Profit Margin (TTM) -982.39 -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 101,814 22,626,821 846,830,978
Net Income/Employee (TTM) -1,000,203 2,971,371 99,616,195
Receivable Turnover (TTM) 0.73 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.07 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.01 -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -87.80 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -88.10 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 24 53
13 Week -20.95 -24.80 19 65
26 Week -24.27 -30.03 25 77
52 Week 15.92 -1.75 60 50
YTD 39.26 22.30 69 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.47%
# of Holders: 54
Total Shares Held: 28,810,277
3 Mo. Net Change: 3,411,734
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.